Prognosis Forecast of Re-Irradiation for Recurrent Nasopharyngeal Carcinoma Based on Deep Learning Multi-Modal Information Fusion-Reference-Cited by-同舟云学术

Prognosis Forecast of Re-Irradiation for Recurrent Nasopharyngeal Carcinoma Based on Deep Learning Multi-Modal Information Fusion

Published:2023-12 Issue:12 Volume:27 Page:6088-6099
ISSN:2168-2194
Container-title:IEEE Journal of Biomedical and Health Informatics
language:
Short-container-title:IEEE J. Biomed. Health Inform.

Author:

Lu Shanfu¹^ORCID,Xiao Xiang²^ORCID,Yan Ziye¹,Cheng Tingting³^ORCID,Tan Xufang⁴^ORCID,Zhao Rongchang⁵^ORCID,Wu Haijun⁶,Shen Liangfang⁶^ORCID,Zhang Zijian⁶^ORCID

Affiliation:

1. Perception Vision Medical Technologies Company, Ltd., Guangzhou, China

2. Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China

3. Department of General practice, Xiangya Hospital, Central South University, Changsha, China

4. Department of Nursing, Xiangya Hospital, Central South University, Changsha, China

5. School of Computer Science and Engineering, Central South University, Changsha, China

6. National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China

Funder

Natural Science Foundation of Hunan Province

Clinical Medical Technology Innovation Guidance Project of Hunan Province

Publisher

Institute of Electrical and Electronics Engineers (IEEE)

Subject

Health Information Management,Electrical and Electronic Engineering,Computer Science Applications,Health Informatics

Link

http://xplorestaging.ieee.org/ielx7/6221020/10345388/10168236.pdf?arnumber=10168236

Reference48 articles.

1. A deep learning MR-based radiomic nomogram may predict survival for nasopharyngeal carcinoma patients with stage T3N1M0

2. Global trends in incidence and mortality of nasopharyngeal carcinoma

3. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

4. Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety

5. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience